183 related articles for article (PubMed ID: 22903790)
1. Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
Brookman-May S; May M; Ficarra V; Kainz MC; Kampel-Kettner K; Kohlschreiber S; Wenzl V; Schneider M; Burger M; Wieland WF; Otto W; Tilki D; Gilfrich C; Hohenfellner M; Pahernik S; Chromecki TF; Stief C; Zigeuner R;
World J Urol; 2013 Oct; 31(5):1309-16. PubMed ID: 22903790
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma.
Choi JY; Ko YH; Song PH
Investig Clin Urol; 2016 Sep; 57(5):324-9. PubMed ID: 27617313
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy.
O'Keefe SC; Marshall FF; Issa MM; Harmon MP; Petros JA
J Urol; 2002 Oct; 168(4 Pt 1):1378-80. PubMed ID: 12352397
[TBL] [Abstract][Full Text] [Related]
5. Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies.
Wosnitzer M; Polland A; Hai Q; Hruby G; McKiernan J
BJU Int; 2011 Jul; 108(1):73-9. PubMed ID: 21166746
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
8. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
9. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma.
Göğüş C; Baltaci S; Filiz E; Elhan A; Bedük Y
Urology; 2004 Mar; 63(3):447-50. PubMed ID: 15028435
[TBL] [Abstract][Full Text] [Related]
10. Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
Int J Clin Oncol; 2018 Feb; 23(1):142-150. PubMed ID: 28791497
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Hutterer GC; Krieger D; Mrsic E; Pohlmann K; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Pichler M
Anticancer Res; 2015 Jun; 35(6):3463-9. PubMed ID: 26026111
[TBL] [Abstract][Full Text] [Related]
12. The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma.
Mano R; Flynn J; Blum KA; Silagy AW; DiNatale RG; Marcon J; Wang A; Sanchez A; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
Urol Oncol; 2019 Dec; 37(12):916-923. PubMed ID: 31590969
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
14. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
15. Preoperative anaemia and thrombocytosis predict adverse prognosis in non-metastatic renal cell carcinoma with tumour thrombus.
Xiao R; Xu C; He W; Liu L; Zhang H; Liu C; Ma L
BMC Urol; 2021 Feb; 21(1):31. PubMed ID: 33639914
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the Controlling Nutritional Status score following curative nephrectomy for patients with renal cell carcinoma.
Zheng Y; Bao L; Wang W; Wang Q; Pan Y; Gao X
Medicine (Baltimore); 2018 Dec; 97(49):e13409. PubMed ID: 30544418
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Suppiah R; Shaheen PE; Elson P; Misbah SA; Wood L; Motzer RJ; Negrier S; Andresen SW; Bukowski RM
Cancer; 2006 Oct; 107(8):1793-800. PubMed ID: 16983701
[TBL] [Abstract][Full Text] [Related]
18. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract][Full Text] [Related]
20. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
Brookman-May SD; May M; Shariat SF; Novara G; Zigeuner R; Cindolo L; De Cobelli O; De Nunzio C; Pahernik S; Wirth MP; Longo N; Simonato A; Serni S; Siracusano S; Volpe A; Morgia G; Bertini R; Dalpiaz O; Stief C; Ficarra V; ; ;
BJU Int; 2013 Nov; 112(7):909-16. PubMed ID: 23890378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
